Page last updated: 2024-08-22

camptothecin and Syndrome

camptothecin has been researched along with Syndrome in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosokawa, T; Ishikawa, T; Kanazawa, M; Kanbayashi, Y; Kawano, R; Nakajima, Y; Tabuchi, Y; Taguchi, T; Takayama, K; Yoshida, N; Yoshioka, T1
Fujita, KI; Ishida, H; Iwai, S; Kamei, D; Kubota, Y; Sasaki, Y; Taki-Takemoto, I; Tsuboya, A1
Darroudi, F; de Groot, J; de Winter, JP; Godthelp, BC; Joenje, H; Oostra, AB; Scheper, RJ; Steltenpool, J; van der Lelij, P; van Gosliga, D; van Zon, W; Waisfisz, Q; Wolthuis, RM1
Carpenter, G; Chiang, SC; El-Khamisy, S; Kerzendorfer, C; O'Driscoll, M; Outwin, E; Raymond, FL; Schwartz, C; Turner, G; Whibley, A1
Innocenti, F; Ratain, MJ1
Asaka, M; Furukawa, S; Fuse, N; Kato, M; Kato, T; Komatsu, Y; Takeda, H; Takei, M; Yuki, S1
Cuvier, C; Cvitkovic, E; Goldwasser, F; Marty, M; Misset, JL; Wasserman, E1
Eckardt-Schupp, F; Friedl, AA; Jaspers, NG; Klein, B; Kraakman-van der Zwet, M; Lohman, PH; Midro, AT; Overkamp, WJ; Verhaegh, GW; Zdzienicka, MZ1
Meropol, NJ; Poplin, EA; Rothenberg, ML; Van Cutsem, E; Wadler, S1
Bleiberg, H; Di Leo, A1

Reviews

1 review(s) available for camptothecin and Syndrome

ArticleYear
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.
    Oncology (Williston Park, N.Y.), 2003, Volume: 17, Issue:5 Suppl 5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Glucuronosyltransferase; Humans; Irinotecan; Neoplasms; Polymorphism, Genetic; Syndrome

2003

Other Studies

9 other study(ies) available for camptothecin and Syndrome

ArticleYear
Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis.
    Medical oncology (Northwood, London, England), 2018, Apr-28, Volume: 35, Issue:6

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Camptothecin; Diarrhea; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Logistic Models; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Quality of Life; Retrospective Studies; Salivation; Syndrome; Young Adult

2018
Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer.
    International journal of clinical oncology, 2019, Volume: 24, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cholinergic Agents; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Irinotecan; Japan; Male; Middle Aged; Neoplasms; Prognosis; Quality of Life; Retrospective Studies; Risk Factors; Syndrome

2019
The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2.
    PloS one, 2009, Sep-07, Volume: 4, Issue:9

    Topics: Acetyltransferases; Camptothecin; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Chromosome Aberrations; Chromosome Segregation; Cohesins; Congenital Abnormalities; DNA Damage; Etoposide; Fibroblasts; Growth Disorders; Humans; Infant; Male; Mitomycin; Nucleic Acid Synthesis Inhibitors; Sister Chromatid Exchange; Syndrome

2009
Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks.
    Human molecular genetics, 2010, Apr-01, Volume: 19, Issue:7

    Topics: Abnormalities, Multiple; Camptothecin; Cell Line; Cullin Proteins; DNA Damage; DNA Topoisomerases, Type I; Humans; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome; Ubiquitination

2010
Treatment of a Gilbert's syndrome patient with irinotecan, leucovorin and 5-fluorouracil.
    Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Fluorouracil; Gilbert Disease; Glucuronosyltransferase; Humans; Irinotecan; Leucovorin; Male; Mutation; Syndrome; Treatment Outcome

2005
Re: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.
    Journal of the National Cancer Institute, 1998, Jul-01, Volume: 90, Issue:13

    Topics: Abdominal Pain; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cholinergic Fibers; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Parasympathomimetics; Receptors, Cholinergic; Syndrome

1998
Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts.
    Mutation research, 1999, May-14, Volume: 434, Issue:1

    Topics: Abnormalities, Multiple; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Line; Cell Line, Transformed; Cell Survival; Cell Transformation, Viral; Child, Preschool; Chromosome Breakage; DNA; DNA Damage; DNA Repair; Etoposide; Fibroblasts; HeLa Cells; Humans; Mitomycin; Mutation; Syndrome; X-Rays

1999
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-15, Volume: 19, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of Death; Fluorouracil; Gastrointestinal Diseases; Guidelines as Topic; Irinotecan; Leucovorin; Mortality; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Time Factors; Vascular Diseases

2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-15, Volume: 20, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardiovascular Diseases; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Syndrome; Thrombosis

2002